1. Resources >>
  2. Companies directory >>
  3. Casebia Therapeutics
Casebia Therapeutics

Casebia Therapeutics

Bayer and CRISPR Therapeutics have entered into an agreement to create Casebia to discover, develop and commercialize new breakthrough therapeutics to cure blood disorders, blindness, and congenital heart disease. CRISPR Therapeutics will contribute its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer will make available its protein engineering expertise and relevant disease know-how.
Headquarters
CAMBRIDGE, MA
Company size
10,001+ employees
Specialties
Scientific Innovation, Medical Breakthroughs, Gene-editing technology, Protein Engineering, Breakthrough Human Therapeutics, CRISPR-Cas9 gene editing technology, Patient Focused, Hematology, Ophthalmology, Genetic Diseases, Rare Disease
Top employees at
Casebia Therapeutics
E
Eric Celidonio
Recruiting Process Outsourcing Leader
Hingham, Massachusetts
L
Lori Stocker
Sr. Recruiter
Greater New York City Area
D
Dariusz Wodziak
Research Associate II
San Francisco Bay Area
K
Karen Vo
Scientist
San Francisco, California
G
Greg Boucher
Senior Research Associate, Hematology
San Francisco Bay Area

Companies, you might be interested in:

Caseblocks
Casebolt Design Co., LLC
Casebook PBC
CaseCentral
The most popular email templates:
Casebia Therapeutics’s email formatsPercentage
lastNameInitial_firstNameInitiald_j@casebia.com76%
firstNameInitiallastNameInitialjd@casebia.com31%
lastNameInitial-firstNamed-jane@casebia.com72%
lastNameInitial.firstNamed.jane@casebia.com74%
lastName.firstNameInitialdoe.j@casebia.com94%
firstNamelastNameInitialjaned@casebia.com80%

Our Integration Partners

+ 13 more